Article
Why turning patient intent into action is pharma's next commercial opportunity
Published
9 October 2026
Patients now arrive at their doctor’s consultation having looked things up, formed a view of what is wrong, and decided what to ask. Whether to seek care, when to do it, and what to raise are decisions that increasingly sit with the patient - shaped by search results, social media, and AI assistants that are available 24/7. Most of that shaping happens without pharma companies playing an active role the patient’s journey.
While most pharma companies already fund disease awareness and patient adherence, the crucial step in between – where intent is turned into action – is often left to chance. A patient who recognises their symptoms but never books an appointment never gets the help they need – and never moves the needle for the business.
Patient activation closes that gap deliberately. It removes the friction between intent and action, so patients go from being simply aware, to actually booking an appointment with their doctor.
Download the full whitepaper to learn what patient activation is, why it’s one of pharma's biggest commercial opportunities right now, how to get started, and what we have learned from helping pharma companies build and scale it.
Download the whitepaper
Sign up to receive the whitepaper and learn more about pharma’s next commercial opportunity.
Any questions?
Reach out to our patient activation experts:Â
Related0 4
Article
Read more
AI in grocery retail​
Grocery retailers can use AI to improve decisions, margins and customer relevance.Article
Read more
The execution gap
How the U.S. life sciences industry is winning the science race and losing the transformation battle.Article
Read more
AI in life sciences​
Life sciences companies are investing in AI, but value depends on adoption, compliance and better workflows.Article
Read more




